Module 117 -- Signaling

Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets: 2
Num genes: 731 (see 3382 additional genes for this module)
Num experiments: 1014 (335 induced, 679 repressed)
Parent module: None
Children modules: None


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
Nutt03 44
Lessnick02 38


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation Category P-value Hits Hits(%) Module hits in category Arrays in annotation Arrays
Liver tissue (Liver cancer*) Liver cancer* 8.1e-43 110 32.8 335 187 1945
Liver tissue, cancer or cell line (Liver cancer*) Liver cancer* 1.0e-39 110 32.8 335 197 1945
Acute leukemia (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Cancer and cell line (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Cancer (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Hematologic cancer and cell line (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Hematologic cancer (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Hematologic samples and cell lines (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Leukemia (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Leukemia or leukemia cell line (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Monocytes (Leukemia*) Leukemia* 2.2e-37 120 17.6 679 141 1945
Hepatitis infected liver (Liver cancer*) Liver cancer* 1.7e-32 89 26.5 335 156 1945
Cancer and cell line (Liver cancer) Liver cancer 2.4e-23 87 96.6 90 126 207
Non-tumor liver tissue (Liver cancer) Liver cancer 2.4e-22 72 65.4 110 76 207
Hematologic samples and cell lines (B lymphoma) B lymphoma 2.9e-16 78 81.2 96 121 245
Cancer and cell line (Various tumors*) Various tumors* 4.8e-15 75 11.0 679 105 1945
Cancer (Various tumors*) Various tumors* 4.8e-15 75 11.0 679 105 1945
Hematologic cancer and cell line (Stimulated PBMC) Stimulated PBMC 1.3e-14 19 82.6 23 30 182
Macrophages (Stimulated PBMC) Stimulated PBMC 1.3e-14 19 82.6 23 30 182
Breast tissue or cancer (Breast cancer*) Breast cancer* 1.5e-14 55 16.4 335 118 1945
Female hormonal tissue or cancer (Breast cancer*) Breast cancer* 1.5e-14 55 16.4 335 118 1945
Cancer (Liver cancer) Liver cancer 5.3e-14 76 84.4 90 115 207
Adenocarcinoma (Breast cancer*) Breast cancer* 1.0e-13 52 15.5 335 112 1945
Breast cancer (Breast cancer*) Breast cancer* 1.0e-13 52 15.5 335 112 1945
Cancer (Breast cancer*) Breast cancer* 1.0e-13 52 15.5 335 112 1945
Female hormonal cancer (Breast cancer*) Breast cancer* 1.0e-13 52 15.5 335 112 1945
Lymphoma (B lymphoma) B lymphoma 2.3e-11 54 56.2 96 77 245
Female hormonal cancer or cell line (Breast cancer*) Breast cancer* 4.7e-11 52 15.5 335 127 1945
Breast cancer or cell line (Breast cancer*) Breast cancer* 6.8e-11 52 15.5 335 128 1945
Female hormonal tissue, cancer or cell line (Breast cancer*) Breast cancer* 1.1e-10 55 16.4 335 141 1945
Breast tissue, cancer or cell line (Breast cancer*) Breast cancer* 1.6e-10 55 16.4 335 142 1945
Adenocarcinoma (Liver cancer) Liver cancer 3.7e-09 63 70 90 97 207
Cancer and cell line (Breast cancer*) Breast cancer* 8.0e-09 52 15.5 335 143 1945
Invasive liver tumor (Liver cancer) Liver cancer 1.5e-08 32 35.5 90 38 207
Hepatocellular carcinoma (Liver cancer) Liver cancer 2.1e-08 65 72.2 90 104 207
Activated B like DLBCL (B lymphoma) B lymphoma 4.2e-08 17 42.5 40 30 245
Diffuse large B cell lymphoma - DLBCL (B lymphoma) B lymphoma 2.2e-07 35 87.5 40 126 245
Diffuse large B cell lymphoma tumor or cell line (B lymphoma) B lymphoma 1.9e-06 35 87.5 40 134 245
B. petrussis A2 stimulated immune cells (Stimulated PBMC) Stimulated PBMC 9.0e-06 5 31.2 16 5 144
Cell line (Liver cancer) Liver cancer 7.2e-05 11 12.2 90 11 207
Normal tissue (Liver cancer) Liver cancer 9.4e-05 14 12.7 110 14 207
Lymphoma or lymphoma cell line (B lymphoma) B lymphoma 9.4e-05 37 92.5 40 167 245
Breast cancer cell line (Breast cancer) Breast cancer 0.0001 13 25.4 51 17 152
Liver cancer cell line (Liver cancer) Liver cancer 0.0001 10 11.1 90 10 207
Metastasis (Liver cancer) Liver cancer 0.0001 10 11.1 90 10 207
Cell line (Breast cancer) Breast cancer 0.0001 19 37.2 51 30 152
GC B like DLBCL (B lymphoma) B lymphoma 0.0002 18 45 40 53 245
Breast tissue or cancer (NCI60) NCI60 0.0004 4 19.0 21 4 139
Female hormonal tissue or cancer (NCI60) NCI60 0.0004 4 19.0 21 4 139


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation P-value Hits Hits(%) Module genes Genes in annotation Genes
response to biotic stimulus 1.2e-08 118 21.1 558 600 4566
chymotrypsin activity 1.2e-06 19 3.4 558 48 4566
secretion 1.4e-06 55 9.8 558 240 4566
trypsin activity 2.5e-06 19 3.4 558 50 4566
cell-cell signaling 9.7e-06 45 8.0 558 194 4566
immune response 1.0e-05 88 15.7 558 469 4566
integral to plasma membrane 1.5e-05 108 19.3 558 612 4566
receptor binding 1.8e-05 51 9.1 558 235 4566
catabolism 6.9e-05 46 8.2 558 215 4566


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Visual display
Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.
You can also view the images within GeneXPress by loading the module gxp file file.
Note: Since there are 731 genes, this image does not display the individual gene names, but rather condenses each gene to a single pixel without displaying its name. You can fully view the image for this module within GeneXPress, by loading any of the four files mentioned in the line above.
Note: Since there are 1014 experiments, this image does not display the individual experiment names, but rather condenses each experiment to a single pixel without displaying its name. You can fully view the image for this module within GeneXPress, by loading any of the four files mentioned in the line above
 
 





 >4x